Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
Concert Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Concert Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Concert Pharmaceuticals received on average a compensation package of $2.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at Concert Pharmaceuticals
Roger D. Tung, Chief Executive Officer, received $2.8M in total, which decreased by 40% compared to 2018. 68% of Tung's compensation, or $1.9M, was in option awards. Tung also received $309K in non-equity incentive plan, $562K in salary, as well as $11K in other compensation.
Marc Becker, Chief Financial Officer, received a compensation package of $1.9M, which decreased by 23% compared to previous year. 55% of the compensation package, or $1M, was in option awards.
James V. Cassella, Chief Development Officer, earned $1.7M in 2019.
Related executives
You may also like
Source: SEC filing on April 28, 2020.